Combination of Dasatinib and Peg-Interferon alpha 2b in Chronic Phase Chronic Myeloid Leukemia first line: 24-Months results of a Phase II academic trialL. Roy,J. C. Chomel,J. Guilhot,M. Molimard,A. Guerci,M. Escoffre-Barbe,S. Giraudier,A. Charbonnier,V. Dubruille,F. Huguet,H. Johnson-Ansah,P. Lenain,S. Ame,G. Etienne,F. E. Nicolini,D. Rea,P. Cony Makhoul,S. Courby,J. C. Ianotto,L. Legros,M. Delain,V. Coiteux,E. Hermet,M. Gardembas,J. M. Cayuela, M. Thibaud, S. Duranton,F. X. Mahon, P. Rousselot,F. GuilhotFUNDAMENTAL & CLINICAL PHARMACOLOGY（2018）引用 0|浏览45暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
